This inventor holds 1 USPTO granted patent and 6 published patent applications and 5 EPO patents. Top assignee: Metriopharm Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Petra Schulz: Innovator in Pulmonary Disease Treatment
Introduction
Petra Schulz is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of rare chronic inflammatory pulmonary diseases. Her innovative approach has led to the development of a unique pharmaceutical application.
Latest Patents
Petra Schulz holds 1 patent for her invention titled "Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of rare chronic inflammatory pulmonary diseases." This patent focuses on the use of 5-amino-2,3-dihydro-1,4-phthalazinedione or its pharmaceutically acceptable salts for treating these specific diseases. Notably, the invention emphasizes the sodium salt form of this compound for therapeutic purposes.
Career Highlights
Petra Schulz is currently associated with Metriopharm AG, where she continues to advance her research and development efforts. Her work is pivotal in addressing unmet medical needs in the field of pulmonary health.
Collaborations
Petra collaborates with esteemed colleagues, including Wolfgang Brysch and Sara Schumann, who contribute to her research initiatives and help drive innovation within the company.
Conclusion
Petra Schulz's contributions to the treatment of chronic pulmonary diseases exemplify her dedication to medical innovation. Her patent and ongoing work at Metriopharm AG highlight her role as a key figure in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile